ACAD vs BFAM
ACADIA PHARMACEUTICALS INC vs BRIGHT HORIZONS FAMILY SOLUTIONS INC. — Side-by-Side Stock Comparison
ACAD
ACADIA PHARMACEUTICALS INC
4.3
Weak
$20.69
BFAM
BRIGHT HORIZONS FAMILY SOLUTIONS INC.
8.4
Strong Buy
$68.25
ACAD vs BFAM: Which is the Better Investment?
ACADIA PHARMACEUTICALS INC (ACAD) scores 4.3/10 while BRIGHT HORIZONS FAMILY SOLUTIONS INC. (BFAM) scores 8.4/10 on AlphaStocks' composite model. BRIGHT HORIZONS FAMILY SOLUTIONS INC. has the higher composite rating of Strong Buy. On a P/E basis, ACADIA PHARMACEUTICALS INC trades at 9.0x, making it the more attractively priced of the two.
This comparison is algorithmically generated and is not financial advice.
| Metric | ACAD | BFAM |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 4.3/10 | 8.4/10▲ |
| Rating | Weak | Strong Buy▲ |
| Price | $20.69 | $68.25 |
| P/E Ratio | 9.0▲ | 20.3 |
| ROE | 12.9% | 14.0%▲ |
| Market Cap | $4B | $4B |
| Fair Value | — | $64.30 |
| Dividend Yield | — | — |
| Sector Rank | #775 of 1125 | #1 of 1125▲ |
| Model Verdicts | ||
| Piotroski | Attractive | Strong▲ |
| Buffett | Neutral | Strong▲ |
| Graham | Neutral▲ | Caution |
| Lynch | Limited Data | Neutral▲ |
| Greenblatt | Limited Data | Attractive▲ |
ACAD vs BFAM: Which Stock Scores Higher?
ACADIA PHARMACEUTICALS INC (ACAD) and BRIGHT HORIZONS FAMILY SOLUTIONS INC. (BFAM) are among the most compared stocks in the S&P 500. BFAM currently leads with a composite score of 8.4/10 (Strong Buy) compared to ACAD's 4.3/10 (Weak).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer